Drug profile · INN
hydroxypropyl cellulose
LACRISERT
hydroxypropyl cellulose (LACRISERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — hydroxypropyl cellulose
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 8
- Data quality
- 0.84
Quick answer
hydroxypropyl cellulose (LACRISERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is hydroxypropyl cellulose?
hydroxypropyl cellulose (LACRISERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for hydroxypropyl cellulose?
LACRISERT is a marketed brand name for hydroxypropyl cellulose. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxypropyl cellulose?
hydroxypropyl cellulose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.